-transparent.png){kind=logo}
In 14 patients with myeloproliferative disorders associated with thrombocytosis, neurological and neuropsychological function were monitored prior to therapy with recombinant human interferon alpha (rIFN; dose 25 mU/week; range 10-35 mU/week) and after 3, 6, 9, and 12 months of treatment. No overt neurological side effects were observed except 1 case of cerebral insult, probably not treatment-related. Attention, memory function, and tapping improved significantly. The P2-N3 amplitudes of visually evoked potentials increased during normalization of platelet counts. Muscular strength and the amplitude of the compound muscle action potential of the median and peroneal nerves increased significantly in an inversely dose-related fashion. In patients with myeloproliferative disorders, long-term therapy with low to intermediate doses of rIFN does not seem to impair neurological function, but rather is associated with enhanced muscle power and the level of mental arousal.
N Mayr, and
J Zeitlhofer, and
L Deecke, and
E Fritz, and
H Ludwig, and
H Gisslinger
January 1994,
Rivista europea per le scienze mediche e farmacologiche = European review for medical and pharmacological sciences = Revue europeenne pour les sciences medicales et pharmacologiques,
N Mayr, and
J Zeitlhofer, and
L Deecke, and
E Fritz, and
H Ludwig, and
H Gisslinger
December 1992,
Clinical and experimental immunology,
N Mayr, and
J Zeitlhofer, and
L Deecke, and
E Fritz, and
H Ludwig, and
H Gisslinger
January 1991,
The British journal of dermatology,
N Mayr, and
J Zeitlhofer, and
L Deecke, and
E Fritz, and
H Ludwig, and
H Gisslinger
March 1996,
Hematological oncology,
N Mayr, and
J Zeitlhofer, and
L Deecke, and
E Fritz, and
H Ludwig, and
H Gisslinger
January 1991,
Progress in clinical and biological research,
N Mayr, and
J Zeitlhofer, and
L Deecke, and
E Fritz, and
H Ludwig, and
H Gisslinger
May 1989,
Cancer,
N Mayr, and
J Zeitlhofer, and
L Deecke, and
E Fritz, and
H Ludwig, and
H Gisslinger
July 2004,
Journal of viral hepatitis,
N Mayr, and
J Zeitlhofer, and
L Deecke, and
E Fritz, and
H Ludwig, and
H Gisslinger
January 1993,
Journal of biological regulators and homeostatic agents,
N Mayr, and
J Zeitlhofer, and
L Deecke, and
E Fritz, and
H Ludwig, and
H Gisslinger
December 2004,
Journal of gastroenterology and hepatology,
N Mayr, and
J Zeitlhofer, and
L Deecke, and
E Fritz, and
H Ludwig, and
H Gisslinger
November 1997,
Endoscopy,
